Cresco Labs Inc. Press Releases https://investors.crescolabs.com/generated by Q4Fri, 06 Nov 2026 09:40:41 -0500Copyright Q4 Inc. All rights reserved.Cresco Labs Reports Third Quarter 2026 Financial Resultse9e1e433-bc9b-45be-ae77-d041644617f7https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Reports-Third-Quarter-2026-Financial-Results/default.aspxFri, 06 Nov 2026 06:30:00 -0500Cresco Labs Advances Innovation Pipeline with High Supply SLIPS and Wonder THC Drink Mixes4dbd9e2e-c1e5-4e14-8b7e-56c73cb6e5c2https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Advances-Innovation-Pipeline-with-High-Supply-SLIPS-and-Wonder-THC-Drink-Mixes/default.aspxThu, 05 Nov 2026 06:30:00 -0500Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholderscc71742a-000d-4d60-adfa-088404b10490https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Announces-Voting-Results-of-Its-Annual-General-and-Special-Meeting-of-Shareholders/default.aspxMon, 02 Nov 2026 06:30:00 -0500Cresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical Cannabis3c3e2dbe-2b63-474c-a2a7-4f76ae41d6e5https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Celebrates-Sunnyside-Prestonsburg-Grand-Opening-Marking-Major-Milestone-for-Kentucky-Medical-Cannabis/default.aspxFri, 23 Oct 2026 06:30:00 -0400Cresco Labs to Report Third Quarter 2026 Financial Results on November 6, 202638926d68-5e89-4824-9a32-578b2128338chttps://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-to-Report-Third-Quarter-2026-Financial-Results-on-November-6-2026/default.aspxThu, 15 Oct 2026 06:30:00 -0400Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting47d42298-1303-4e96-984b-8c59cceac533https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Announces-Filing-of-Supplement-to-Management-Information-Circular-for-Annual-General-and-Special-Meeting/default.aspxFri, 09 Oct 2026 17:00:00 -0400Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting987dfa53-5f59-4a44-96b4-b1422c146340https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Announces-Filing-of-Management-Information-Circular-for-Annual-General-and-Special-Meeting/default.aspxThu, 24 Sep 2026 17:54:00 -0400Cresco Labs Appoints Edward Tilly to Board of Directorsea9d472d-f1bb-4832-a91e-7411a58b721fhttps://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Appoints-Edward-Tilly-to-Board-of-Directors/default.aspxThu, 17 Sep 2026 06:30:00 -0400Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadershipc0550207-fb27-4895-8d50-d204b96fa9c4https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Acquires-Nine-Pennsylvania-Dispensaries-in-Accretive-Transaction-to-Strengthen-Market-Leadership/default.aspxWed, 02 Sep 2026 06:30:00 -0400Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA91a55dfd-89d8-4ba9-8df5-4e7147b34243https://investors.crescolabs.com/news/news-details/2026/Cresco-Labs-Reports-Second-Quarter-2026-Financial-Results-Delivers-173-Million-in-Revenue-and-40-Million-in-Adjusted-EBITDA/default.aspxThu, 06 Aug 2026 06:30:00 -0400